# Influenza Vaccine Challenge Study in Healthy Subjects

> **NCT01226758** · PHASE1 · COMPLETED · sponsor: **PepTcell Limited** · enrollment: 32 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza vaccine (FLU-v)
- **BIOLOGICAL:** Placebo (adjuvant only)

## Key facts

- **NCT ID:** NCT01226758
- **Lead sponsor:** PepTcell Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2012-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01226758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01226758, "Influenza Vaccine Challenge Study in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01226758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*